Vanda Pharmaceuticals, Inc. (VNDA)
6.50
+0.28
(+4.50%)
USD |
NASDAQ |
May 27, 15:01
Vanda Pharmaceuticals Free Cash Flow : -127.30M for March 31, 2026
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| AnaptysBio, Inc. | 4.409M |
| Amgen, Inc. | 8.597B |
| Gossamer Bio, Inc. | -170.32M |
| BridgeBio Pharma, Inc. | -452.02M |
| Geron Corp. | -126.13M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -50.22M |
| Cash from Investing (Quarterly) | 20.23M |
| Cash from Financing (Quarterly) | -0.776M |
| Free Cash Flow Per Share (Quarterly) | -0.8483 |
| Free Cash Flow to Equity (Quarterly) | -50.89M |
| Free Cash Flow to Firm (Quarterly) | -50.44M |
| Free Cash Flow Yield | -33.10% |